292 related articles for article (PubMed ID: 26129890)
1. Effects of host response and antifungal therapy on serum and BAL levels of galactomannan and (1→3)-β-D-glucan in experimental invasive pulmonary aspergillosis.
Petraitiene R; Petraitis V; Bacher JD; Finkelman MA; Walsh TJ
Med Mycol; 2015 Aug; 53(6):558-68. PubMed ID: 26129890
[TBL] [Abstract][Full Text] [Related]
2. Comparison of 1,3-β-d-glucan with galactomannan in serum and bronchoalveolar fluid for the detection of Aspergillus species in immunosuppressed mechanical ventilated critically ill patients.
Lahmer T; Neuenhahn M; Held J; Rasch S; Schmid RM; Huber W
J Crit Care; 2016 Dec; 36():259-264. PubMed ID: 27475024
[TBL] [Abstract][Full Text] [Related]
3. Impact of bronchoalveolar lavage galactomannan on the outcome of patients at risk for invasive pulmonary aspergillosis.
Danpornprasert P; Foongladda S; Tscheikuna J
J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S86-93. PubMed ID: 20364562
[TBL] [Abstract][Full Text] [Related]
4. Combination Therapy with Isavuconazole and Micafungin for Treatment of Experimental Invasive Pulmonary Aspergillosis.
Petraitis V; Petraitiene R; McCarthy MW; Kovanda LL; Zaw MH; Hussain K; Shaikh N; Maung BBW; Sekhon NK; Hope WW; Walsh TJ
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28696236
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of glucan and galactomannan tests with real-time PCR for diagnosis of invasive aspergillosis in a neutropenic rat model].
Aydoğan S; Kuştimur S; Kalkancı A
Mikrobiyol Bul; 2010 Jul; 44(3):441-52. PubMed ID: 21063994
[TBL] [Abstract][Full Text] [Related]
6. The initial 96 hours of invasive pulmonary aspergillosis: histopathology, comparative kinetics of galactomannan and (1->3) β-d-glucan and consequences of delayed antifungal therapy.
Hope WW; Petraitis V; Petraitiene R; Aghamolla T; Bacher J; Walsh TJ
Antimicrob Agents Chemother; 2010 Nov; 54(11):4879-86. PubMed ID: 20713673
[TBL] [Abstract][Full Text] [Related]
7. Detection and measurement of fungal burden in a guinea pig model of invasive pulmonary aspergillosis by novel quantitative nested real-time PCR compared with galactomannan and (1,3)-β-D-glucan detection.
Lengerova M; Kocmanova I; Racil Z; Hrncirova K; Pospisilova S; Mayer J; Najvar LK; Wiederhold NP; Kirkpatrick WR; Patterson TF
J Clin Microbiol; 2012 Mar; 50(3):602-8. PubMed ID: 22189110
[TBL] [Abstract][Full Text] [Related]
8. [Comparison of the Results of Galactomannan and Beta Glucan Antigen Tests in the Suspicion of Invasive Pulmonary Aspergillosis].
Çuhadar T; Kalkancı A; Tunçcan Güzel Ö; Yeğin ZA; Özkurt ZN; Köktürk N; Yağcı M
Mikrobiyol Bul; 2023 Apr; 57(2):274-282. PubMed ID: 37067211
[TBL] [Abstract][Full Text] [Related]
9. Combination Therapy with Ibrexafungerp (Formerly SCY-078), a First-in-Class Triterpenoid Inhibitor of (1→3)-β-d-Glucan Synthesis, and Isavuconazole for Treatment of Experimental Invasive Pulmonary Aspergillosis.
Petraitis V; Petraitiene R; Katragkou A; Maung BBW; Naing E; Kavaliauskas P; Barat S; Borroto-Esoda K; Azie N; Angulo D; Walsh TJ
Antimicrob Agents Chemother; 2020 May; 64(6):. PubMed ID: 32179521
[TBL] [Abstract][Full Text] [Related]
10. Detection of invasive pulmonary aspergillosis in critically ill patients by combined use of conventional culture, galactomannan, 1-3-beta-D-glucan and Aspergillus specific nested polymerase chain reaction in a prospective pilot study.
Boch T; Reinwald M; Spiess B; Liebregts T; Schellongowski P; Meybohm P; Rath PM; Steinmann J; Trinkmann F; Britsch S; Michels JD; Jabbour C; Hofmann WK; Buchheidt D
J Crit Care; 2018 Oct; 47():198-203. PubMed ID: 30015290
[TBL] [Abstract][Full Text] [Related]
11. A prospective comparison of galactomannan in bronchoalveolar lavage fluid for the diagnosis of pulmonary invasive aspergillosis in medical patients under intensive care: comparison with the diagnostic performance of galactomannan and of (1→ 3)-β-d-glucan chromogenic assay in serum samples.
Acosta J; Catalan M; del Palacio-Peréz-Medel A; Lora D; Montejo JC; Cuetara MS; Moragues MD; Ponton J; del Palacio A
Clin Microbiol Infect; 2011 Jul; 17(7):1053-60. PubMed ID: 20825441
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and Concentration-Dependent Efficacy of Isavuconazole for Treatment of Experimental Invasive Pulmonary Aspergillosis.
Petraitis V; Petraitiene R; Moradi PW; Strauss GE; Katragkou A; Kovanda LL; Hope WW; Walsh TJ
Antimicrob Agents Chemother; 2016 May; 60(5):2718-26. PubMed ID: 26883703
[TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics, radiologic findings, risk factors and outcomes of serum galactomannan-negative invasive pulmonary aspergillosis.
Jung J; Kim MY; Chong YP; Lee SO; Choi SH; Kim YS; Woo JH; Kim SH
J Microbiol Immunol Infect; 2018 Dec; 51(6):802-809. PubMed ID: 28712819
[TBL] [Abstract][Full Text] [Related]
14. Galactomannan testing in bronchoalveolar lavage fluid facilitates the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies and stem cell transplant recipients.
Nguyen MH; Leather H; Clancy CJ; Cline C; Jantz MA; Kulkarni V; Wheat LJ; Wingard JR
Biol Blood Marrow Transplant; 2011 Jul; 17(7):1043-50. PubMed ID: 21087680
[TBL] [Abstract][Full Text] [Related]
15. [The importance of bronchoalveolar lavage sample for galactomannan, 1,3-ß-d-glucan and PCR tests].
Sav H; Atalay MA; Unal E; Koç N
Mikrobiyol Bul; 2012 Oct; 46(4):695-701. PubMed ID: 23188584
[TBL] [Abstract][Full Text] [Related]
16. Galactomannan detection in bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in patients with hematological diseases-the role of factors affecting assay performance.
Racil Z; Kocmanova I; Toskova M; Buresova L; Weinbergerova B; Lengerova M; Rolencova M; Winterova J; Hrncirova K; Volfova P; Skrickova J; Mayer J
Int J Infect Dis; 2011 Dec; 15(12):e874-81. PubMed ID: 22040924
[TBL] [Abstract][Full Text] [Related]
17. Development of a novel inhalational model of invasive pulmonary aspergillosis in rats and comparative evaluation of three biomarkers for its diagnosis.
Ahmad S; Al-Shaikh AA; Khan Z
PLoS One; 2014; 9(6):e100524. PubMed ID: 24955575
[TBL] [Abstract][Full Text] [Related]
18. The utility of bronchoalveolar lavage beta-D-glucan testing for the diagnosis of invasive fungal infections.
Rose SR; Vallabhajosyula S; Velez MG; Fedorko DP; VanRaden MJ; Gea-Banacloche JC; Lionakis MS
J Infect; 2014 Sep; 69(3):278-83. PubMed ID: 24797077
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic yield of a bronchoalveolar lavage fluid galactomannan assay in patients with negative serum galactomannan results suspected to have invasive pulmonary aspergillosis.
Lim SY; Lee YW; Jung J; Kim MJ; Chong YP; Lee SO; Choi SH; Kim YS; Choi EJ; Park HS; Lee JH; Lee JH; Lee KH; Kim SH
Mycoses; 2021 Sep; 64(9):1124-1131. PubMed ID: 33740824
[TBL] [Abstract][Full Text] [Related]
20. Novel tests for diagnosis of invasive aspergillosis in patients with underlying respiratory diseases.
Prattes J; Flick H; Prüller F; Koidl C; Raggam RB; Palfner M; Eigl S; Buzina W; Zollner-Schwetz I; Thornton CR; Krause R; Hoenigl M
Am J Respir Crit Care Med; 2014 Oct; 190(8):922-9. PubMed ID: 25203869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]